Evidence map›Paper›PMID 22983943›Full record

ReviewCurrent psychiatry reports2012

Bipolar disorder and alcohol use disorder: a review.

Conor K Farren, Kevin P Hill, Roger D Weiss

Abstract readReview
In one paragraph

Review in Current psychiatry reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Aberrant cortico-striato-limbic functional connectivity to alcohol cues in co-occurring bipolar disorder and alcohol use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Molecular mechanisms of alcohol's effects on the human body: A review and update.Journal of biochemical and molecular toxicology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Conor K FarrenTrinity College Dublin, St Patrick's University Hospital, James Street, Dublin 8, Ireland. cfarren@stpatsmail.com
Kevin P Hill
Roger D Weiss

Funding

Mentoring in Drug Abuse and Dual Diagnosis ResearchK24DA022288 · NIDA · MCLEAN HOSPITAL · PI WEISS, ROGER D. · 2007 to 2016
$1.8M
Nabilone for Cannabis Dependence: Imaging and Neuropsychological PerformanceR00DA029115 · NIDA · MCLEAN HOSPITAL · PI HILL, KEVIN P. · 2013 to 2015
$819k
Nabilone for Cannabis Dependence: Imaging and Neuropsychological PerformanceK99DA029115 · NIDA · MCLEAN HOSPITAL · PI HILL, KEVIN P. · 2011 to 2012
$359k
NIDA NIH HHS K24 DA022288NIDA NIH HHS K24DA022288NIDA NIH HHS K99 DA029115NIDA NIH HHS K99/R00DA029115NIDA NIH HHS R00 DA029115
6 · The paper itself

Abstract

Bipolar disorder and alcohol use disorder represent a significant comorbid population, which is significantly worse than either diagnosis alone in presentation, duration, co-morbidity, cost, suicide rate, and poor response to treatment. They share some common characteristics in relation to genetic background, neuroimaging findings, and some biochemical findings. They can be treated with separate care, or ideally some form of integrated care. There are a number of pharmacotherapy trials, and psychotherapy trials that can aid program development. Post-treatment prognosis can be influenced by a number of factors including early abstinence, baseline low anxiety, engagement with an aftercare program and female gender. The future development of novel therapies relies upon increased psychiatric and medical awareness of the co-morbidity, and further research into novel therapies for the comorbid group.

Indexed as

Alcohol-Related DisordersBipolar DisorderComorbidityDiagnosis, Dual (Psychiatry)FemaleHumansMalePsychotherapyPsychotropic DrugsPsychotropic Drugs

Identifiers

PMID22983943
PMCPMC3730445

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.